Posted on July 9, 2024 Pendopharm signs exclusive distribution agreement with Ascendis Pharma A/S for TransCon™ PTH in Canada Read More
Posted on May 16, 2024 Pendopharm renews distribution agreement with Anika Therapeutics Inc. for Cingal®, Monovisc®, and Orthovisc® Read More
Posted on April 6, 2023 Pendopharm announces the launch of Octasa® 1600 mg tablets in Canada Read More
Posted on May 3, 2021 Pendopharm, a division of Pharmascience Inc, is proud to launch SportVisTM to relieve pain and restore function in damaged tendons and ligaments Read More